Received-SPF: pass (google.com: domain of dohs-alcuintb-group+bncbdxkvkgkuenbb4wftt2akgqehnkbo6i@york.ac.uk designates 209.85.220.69 as permitted sender) client-ip=209.85.220.69;
Received-SPF: pass (google.com: domain of christina.vanderfeltz-cornelis@york.ac.uk designates 209.85.220.41 as permitted sender) client-ip=209.85.220.41;
MIME-Version: 1.0
From: Christina Van Der Feltz-Cornelis <christina.vanderfeltz-cornelis@york.ac.uk>
Date: Fri, 3 Apr 2020 12:49:32 +0100
Message-ID: <CAFUB_JBgr48CghQmd=o5GTedjQQ2svKL5zQ52mhgBTByL6rt1Q@mail.gmail.com>
Subject: [ Dohs - Everyone ] Call for papers on mental health in COVID19 research
To: Dohs - Everyone <dohs-everyone-group@york.ac.uk>
Content-Type: multipart/alternative; boundary="000000000000e3209c05a2618404"
Precedence: list
Mailing-list: list dohs-alcuintb-group@york.ac.uk; contact dohs-alcuintb-group+owners@york.ac.uk

--000000000000e3209c05a2618404
Content-Type: text/plain; charset="UTF-8"

Dear colleagues,

I hope that you are all doing well.
I would like to draw your attention to the fact that Frontiers started a
research topic on mental health in the time of COVID 19:
Outbreak Investigation: Mental Health in the Time of COVID-19

We welcome papers reporting original data from both the current COVID-19
pandemic and from past major outbreaks, deriving lessons for the current
pandemic, clinical and systematic reviews and country reports.

Manuscripts can be submitted to this Research Topic via the following
journals: Frontiers Psychiatry, Frontiers Sociology, and Frontiers Public
Health. This is the link to Research Topic:
https://www.frontiersin.org/research-topics/13706/outbreak-investigation-mental-health-in-the-time-of-covid-19


For the upcoming 3 months the open access costs are waived.  Deadline for
Abstract submission is May 30, for full Manuscripts June 30.

I am one of the Editors for this topic; if you have any questions, please
let me know.

Kind regards

Christina

*Prof.dr. Christina van der Feltz-Cornelis*
*Chair of Psychiatry and Epidemiology *
*Specialist Associate RCPsych*

Patients with CD/FND have clinically significant neurocognitive deficits in
all neurocognitive domains compared to normative data. They also perform
significantly worse than patients with other SSRD on information processing
speed, but not in other neurocognitive domains. We published these findings
in the Journal of Neuropsychology, the journal of the British Psychological
Society, March 29th. You can read our study here
<https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnp.12206>.


Department of Health Sciences
Hull York Medical School
University of York
Room ARRC/204, Area 4, ARRC Building
Heslington, YO10 5DD
Tel: +44 1904 321361
Email: christina.vanderfeltz-cornelis@york.ac.uk
https://www.york.ac.uk/healthsciences/our-staff/christina-van-der-feltz-cornelis/
Twitter @VanFeltz

[image: Afbeeldingsresultaat voor Hull York Medical School logo transparent]


EMAIL DISCLAIMER http://www.y
<http://www.york.ac.uk/docs/disclaimer/email.htm>ork.ac.uk/doc
<http://www.york.ac.uk/docs/disclaimer/email.htm>s/disclaimer/email.htm
<http://www.york.ac.uk/docs/disclaimer/email.htm>

-- 
You received this message because you are subscribed to the Google Groups "Dohs Staff - AlcuinTB" group.
To unsubscribe from this group and stop receiving emails from it, send an email to dohs-alcuintb-group+unsubscribe@york.ac.uk.
To view this discussion on the web, visit https://groups.google.com/a/york.ac.uk/d/msgid/dohs-alcuintb-group/CAFUB_JBgr48CghQmd%3Do5GTedjQQ2svKL5zQ52mhgBTByL6rt1Q%40mail.gmail.com.

--000000000000e3209c05a2618404
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Dear colleagues,<div><br></div><div>I hope that you are al=
l doing well.</div><div>I would like to draw your attention to the fact tha=
t Frontiers started a research topic on mental health in the time of COVID =
19:=C2=A0<div><h1 class=3D"gmail-teaser-heading" style=3D"margin:0px 0px 8p=
x;line-height:1.28;color:rgb(35,31,32);padding:0px;outline:0px"><font face=
=3D"arial, sans-serif" style=3D"" size=3D"2">Outbreak Investigation: Mental=
 Health in the Time of COVID-19</font></h1></div><div><p style=3D"margin:0p=
x;line-height:1.5em;outline:0px"><font face=3D"arial, sans-serif" style=3D"=
" color=3D"#000000">We welcome papers reporting original data from both the=
 current COVID-19 pandemic and from past major outbreaks, deriving lessons =
for the current pandemic, clinical and systematic reviews and country repor=
ts.</font></p><br class=3D"gmail-Apple-interchange-newline"></div><div><fon=
t face=3D"arial, sans-serif"><span style=3D"color:rgb(2,2,2)">Manuscripts c=
an be submitted to this Research Topic via the following journals:</span>=
=C2=A0Frontiers Psychiatry, Frontiers Sociology, and Frontiers Public Healt=
h. This is the l</font>ink to Research Topic:=C2=A0<a href=3D"https://www.f=
rontiersin.org/research-topics/13706/outbreak-investigation-mental-health-i=
n-the-time-of-covid-19" target=3D"_blank">https://www.frontiersin.org/resea=
rch-topics/13706/outbreak-investigation-mental-health-in-the-time-of-covid-=
19</a>=C2=A0=C2=A0</div><div><br></div><div><div>For the upcoming 3 months =
the open access costs are waived.=C2=A0 Deadline for Abstract submission is=
 May 30, for full Manuscripts June 30.=C2=A0<br></div><div><br></div><div>I=
 am one of the Editors for this topic; if you have any questions, please le=
t me know.</div><br><div dir=3D"ltr" class=3D"gmail_signature" data-smartma=
il=3D"gmail_signature"><div dir=3D"ltr"><div><div dir=3D"ltr"><div dir=3D"l=
tr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><di=
v dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=
=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr=
"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div =
dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"=
ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><d=
iv>Kind regards</div><div><br></div><div>Christina</div><div><br></div><div=
><b>Prof.dr. Christina van der Feltz-Cornelis</b></div><div dir=3D"ltr"><b>=
Chair of Psychiatry and Epidemiology=C2=A0</b></div><div dir=3D"ltr"><b>Spe=
cialist Associate RCPsych</b></div><div dir=3D"ltr"><b><br></b></div><div d=
ir=3D"ltr"><p class=3D"MsoNormal">Patients with CD/FND have clinically sign=
ificant neurocognitive
deficits in all neurocognitive domains compared to normative data. They als=
o
perform significantly worse than patients with other SSRD on information pr=
ocessing
speed, but not in other neurocognitive domains.<span style=3D"background-im=
age:initial;background-position:initial;background-repeat:initial">=C2=A0We=
 published these findings in the Journal of
Neuropsychology, the journal of the British Psychological Society, March 29=
th.
You can read our study <a href=3D"https://onlinelibrary.wiley.com/doi/pdf/1=
0.1111/jnp.12206" target=3D"_blank">here</a>.=C2=A0 =C2=A0</span><br></p></=
div><div dir=3D"ltr"><p class=3D"MsoNormal"><span style=3D"background-image=
:initial;background-position:initial;background-repeat:initial"><br></span>=
</p>Department of Health Sciences=C2=A0<br>Hull York Medical School<br>Univ=
ersity of York<br>Room ARRC/204, Area 4, ARRC Building<br>Heslington, YO10 =
5DD<br>Tel: +44 1904 321361<br>Email: <a href=3D"mailto:christina.vanderfel=
tz-cornelis@york.ac.uk" target=3D"_blank">christina.vanderfeltz-cornelis@yo=
rk.ac.uk</a><br><a href=3D"https://www.york.ac.uk/healthsciences/our-staff/=
christina-van-der-feltz-cornelis/" target=3D"_blank">https://www.york.ac.uk=
/healthsciences/our-staff/christina-van-der-feltz-cornelis/</a><br></div><d=
iv dir=3D"ltr"><div><span style=3D"font-family:Arial,sans-serif;font-size:1=
0pt">Twitter @VanFeltz</span></div></div><div dir=3D"ltr"><span style=3D"fo=
nt-family:Arial,sans-serif"><p style=3D"font-size:10pt"><img src=3D"https:/=
/upload.wikimedia.org/wikipedia/en/7/7c/Hull_York_Medical_School_%28logo%29=
.png" alt=3D"Afbeeldingsresultaat voor Hull York Medical School logo transp=
arent" width=3D"96" height=3D"52" style=3D"font-family:Arial,Helvetica,sans=
-serif;font-size:small">=C2=A0</p><p style=3D"font-size:10pt"><span style=
=3D"font-size:10pt">EMAIL</span><span style=3D"font-size:10pt">=C2=A0D</spa=
n><span style=3D"font-size:10pt">ISCLAIMER=C2=A0</span><span style=3D"font-=
size:10pt;color:rgb(17,85,204)"><a style=3D"color:rgb(17,85,204)" href=3D"h=
ttp://www.york.ac.uk/docs/disclaimer/email.htm" target=3D"_blank">http://ww=
w.y</a></span><span style=3D"font-size:10pt;color:rgb(17,85,204)"><a style=
=3D"color:rgb(17,85,204)" href=3D"http://www.york.ac.uk/docs/disclaimer/ema=
il.htm" target=3D"_blank">ork.ac.uk/doc</a></span><a href=3D"http://www.yor=
k.ac.uk/docs/disclaimer/email.htm" style=3D"font-size:10pt;color:rgb(17,85,=
204)" target=3D"_blank">s/disclaimer/email.htm</a></p></span><span style=3D=
"font-family:Arial,sans-serif"><p style=3D"font-size:10pt"></p><p style=3D"=
font-size:10pt"></p><p style=3D"font-size:10pt"></p></span><div><p class=3D=
"MsoNormal"><br><br><br><br><br><br></p></div></div></div></div></div></div=
></div></div></div></div></div></div></div></div></div></div></div></div></=
div></div></div></div></div></div></div></div></div></div></div></div></div=
></div></div></div></div></div>

<p></p>

-- <br />
You received this message because you are subscribed to the Google Groups &=
quot;Dohs Staff - AlcuinTB&quot; group.<br />
To unsubscribe from this group and stop receiving emails from it, send an e=
mail to <a href=3D"mailto:dohs-alcuintb-group+unsubscribe@york.ac.uk">dohs-=
alcuintb-group+unsubscribe@york.ac.uk</a>.<br />
To view this discussion on the web, visit <a href=3D"https://groups.google.=
com/a/york.ac.uk/d/msgid/dohs-alcuintb-group/CAFUB_JBgr48CghQmd%3Do5GTedjQQ=
2svKL5zQ52mhgBTByL6rt1Q%40mail.gmail.com?utm_medium=3Demail&utm_source=3Dfo=
oter">https://groups.google.com/a/york.ac.uk/d/msgid/dohs-alcuintb-group/CA=
FUB_JBgr48CghQmd%3Do5GTedjQQ2svKL5zQ52mhgBTByL6rt1Q%40mail.gmail.com</a>.<b=
r />

--000000000000e3209c05a2618404--